NEWS

Transvascular access: a new frontier in CSDH care

Intrasaccular aneurysm treatment: Top cases revealed!

Acandis Supports ICARUS Study Advancing Treatment for Stroke Patients wi...

Basel, Switzerland – June 2025 – The University Hospital Basel, under the direction of Prof. Dr. Marios‑Nikos Psychogios, has officially launched the ICARUS study (“IntraCranial Atherosclerosis‑Related Large‑Vessel Occlusion Treated with Urgent Stenting”), with the first patient successfully enrolled in April 2025.

Expanding a Stroke Legacy: Terumo Neuro Announces US Commercial Availabi...

Terumo Neuro’s SOFIA™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility  

Call for grant open: apply now to attend LINNC Asia 2025!

Subdural Hematoma: Preventing Recurrence with a Three-Step Onyx Embolization

LINNC Paris 2025 – A stroke of brilliance and a celebration of innovation on Day 3

Day 2 at LINNC Paris 2025: pushing limits, refining techniques, and imagining the future of neurointervention

Linnc 2025 Day 1: navigating complexity and pushing boundaries

Philips launches intelligent 3D imaging in Europe to empower faster stro...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the CE-marking of its latest SmartCT image reconstruction solution designed to support faster, more informed decision-making in the treatment of stroke and other neurovascular conditions. Already available in Japan and Canada, SmartCT is now CE-marked and available across Europe. The solution will be showcased at LINNC Paris 2025 (June 2–4), the world’s leading interventional neuroradiology congress.